Abstract: Some problems arise in analyzing massive complex data consisting of multivariate response variables and a large number of multicollinear predictor variables, especially when the sample sizes ...

Background PD-1 blockade has emerged as a promising approach for functional cure of chronic hepatitis B (CHB). Objective This study aimed to evaluate the safety profile of anti-PD-1 antibody (αPD-1), ...

Since the start of the season, Ivan Demidov and Oliver Kapanen have been paired on the same line. The two kids, who had shown great things together at the rookie camp, had the opportunity to repeat ...

Objective: To systematically evaluate the impact of exercise interventions on balance performance in children and adolescents with intellectual disabilities and examine the dose–response relationship ...

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...

As the Green Bay Packers prepare for the 2025 campaign, Jordan Love is taking time to push back against certain narratives around his 2024 season. Statistically, the 26-year-old quarterback took a ...

Risankizumab (Skyrizi), a selective anti-interleukin-23 (IL-23) biologic agent, is increasingly used in the treatment of Crohn's disease (CD). A previous head-to-head study has demonstrated its ...

The following is a summary of “Association between the serum alpha-1-acid glycoprotein concentrations and depression in US adult women: a cross-sectional study,” published in the May 2025 issue of BMC ...

The effectiveness of antibiotic treatment depends on a person taking it correctly. Missing several doses of an antibiotic can result in ineffective treatment and potentially contribute to ...

During a live event, Daniel M. Geynisman, MD, and participants discussed which efficacy end points they value and how they modify doses of combination renal cell carcinoma therapies. What efficacy end ...

Researchers headed by teams at the Garvan Institute of Medical Research and at the Kirby Institute at UNSW Sydney have discovered why receiving a vaccine booster in the same arm as the first vaccine ...